NO932552L - Deteksjon av syndekaninnholdet i biologisk materiale saasom vevs- og kroppsvaesker for angivelse av malign transformasjon av celler - Google Patents

Deteksjon av syndekaninnholdet i biologisk materiale saasom vevs- og kroppsvaesker for angivelse av malign transformasjon av celler

Info

Publication number
NO932552L
NO932552L NO93932552A NO932552A NO932552L NO 932552 L NO932552 L NO 932552L NO 93932552 A NO93932552 A NO 93932552A NO 932552 A NO932552 A NO 932552A NO 932552 L NO932552 L NO 932552L
Authority
NO
Norway
Prior art keywords
cells
transformation
malign
tissue
indicating
Prior art date
Application number
NO93932552A
Other languages
English (en)
Other versions
NO932552D0 (no
NO314604B1 (no
Inventor
Markku Tapani Jalkanen
Pirjo Leena Kyllikki Inki
Jarkko Kijavainen
Sirpa Marianne Leppae
Sakari Markku Mali
Original Assignee
Markku Tapani Jalkanen
Pirjo Leena Kyllikki Inki
Jarkko Kijavainen
Sirpa Marianne Leppae
Sakari Markku Mali
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27093707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO932552(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Markku Tapani Jalkanen, Pirjo Leena Kyllikki Inki, Jarkko Kijavainen, Sirpa Marianne Leppae, Sakari Markku Mali filed Critical Markku Tapani Jalkanen
Publication of NO932552D0 publication Critical patent/NO932552D0/no
Publication of NO932552L publication Critical patent/NO932552L/no
Publication of NO314604B1 publication Critical patent/NO314604B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
NO19932552A 1991-01-15 1993-07-14 Deteksjon av syndekaninnholdet i biologisk materiale så som vevs- og kroppsv¶sker for angivelse av malign transformasjon av celler NO314604B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64120991A 1991-01-15 1991-01-15
US72133091A 1991-07-01 1991-07-01
PCT/FI1991/000399 WO1992013274A1 (en) 1991-01-15 1991-12-19 Detection of syndecan content in biological materials such as tissues and body fluids for indications of malignant transformations of cells

Publications (3)

Publication Number Publication Date
NO932552D0 NO932552D0 (no) 1993-07-14
NO932552L true NO932552L (no) 1993-07-14
NO314604B1 NO314604B1 (no) 2003-04-14

Family

ID=27093707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19932552A NO314604B1 (no) 1991-01-15 1993-07-14 Deteksjon av syndekaninnholdet i biologisk materiale så som vevs- og kroppsv¶sker for angivelse av malign transformasjon av celler

Country Status (23)

Country Link
US (1) US5422243A (no)
EP (2) EP0569367B1 (no)
JP (1) JP3103377B2 (no)
KR (1) KR0162670B1 (no)
AT (1) ATE166157T1 (no)
AU (1) AU650936B2 (no)
BG (1) BG61625B1 (no)
CA (1) CA2100077C (no)
CZ (1) CZ282203B6 (no)
DE (1) DE69129417T2 (no)
DK (1) DK0569367T3 (no)
ES (1) ES2116331T3 (no)
FI (1) FI104347B (no)
HU (1) HU215778B (no)
IE (2) IE990011A1 (no)
NO (1) NO314604B1 (no)
NZ (1) NZ241273A (no)
PL (1) PL168188B1 (no)
PT (1) PT100008B (no)
RU (1) RU2139540C1 (no)
SK (1) SK281583B6 (no)
WO (1) WO1992013274A1 (no)
ZA (1) ZA92271B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726058A (en) * 1992-12-01 1998-03-10 Jalkanen; Markku Syndecan stimulation of cellular differentiation
DE69329802T2 (de) * 1992-12-01 2001-07-19 Biotie Therapies Corp Syndecan-stimulierung der zellulären differenzierung
US6017727A (en) * 1994-03-07 2000-01-25 Biotie Therapies Ltd. Syndecan enhancer element and syndecan stimulation of cellular differentiation
US5851993A (en) * 1994-06-13 1998-12-22 Biotie Therapies Ltd. Suppression of tumor cell growth by syndecan-1 ectodomain
GB9519490D0 (en) * 1995-09-25 1995-11-29 Melvin William T Use of a cytochrome P450 enzyme in tumour cells as a marker and target
US6385546B1 (en) 1996-11-15 2002-05-07 Rutgers, The University Of New Jersey Stabilizing and destabilizing proteins
AU756587B2 (en) * 1997-08-12 2003-01-16 Leadd B.V. Determining the transforming capability of agents
AU769125B2 (en) * 1998-10-16 2004-01-15 Regents Of The University Of California, The Glypicans for the detection and treatment of human carcinoma
US6998232B1 (en) * 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
WO2001077682A1 (fr) * 2000-04-10 2001-10-18 Institut Bioorganicheskoi Khimii Imeni Akademikov M.M. Shemyakina I Ju. A. Ovchinnikova Rossiisskoi Akademii Nauk Anticorps diriges contre le facteur hldf, procedes de fabrication correspondants, peptides avec des capacites antigeniques et a hydrolyse hk et procede de diagnostic de l'etat anaplasique de cellules humaines
AU2002338431A1 (en) * 2001-04-04 2002-11-05 Quark Biotech, Inc. Sequence characteristics of bladder cancer
KR100694804B1 (ko) * 2005-05-18 2007-03-14 아주대학교산학협력단 작은 헤어핀 ｒｎａ 분자를 포함하는 자궁 내막암 치료또는 예방용 조성물 및 그를 이용한 자궁 내막암 치료 또는예방 방법
US8347890B2 (en) * 2006-06-19 2013-01-08 Insono Therapeutics, Inc. Automated tissue retention system
WO2009105624A2 (en) * 2008-02-21 2009-08-27 Massachusetts Institute Of Technology Simultaneous delivery of receptors and/or co-receptors for growth factor stability and activity
GB0803272D0 (en) * 2008-02-22 2008-04-02 Smith & Nephew Ultrasound and tissue repair

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3511199A1 (de) * 1985-03-28 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur immunologischen bestimmung von heparansulfat-proteoglykan, verfahren zur herstellung bzw. reinigung von dafuer geeignetem heparansulfat-proteoglykan aus basalmembran-haltigen geweben
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
US4945086A (en) * 1988-05-03 1990-07-31 The Board Of Trustees Of The Leland Stanford Junior University Smooth muscle cell growth inhibitor
JPH02156898A (ja) * 1988-12-08 1990-06-15 Seikagaku Kogyo Co Ltd 抗低密度型ヘパラン硫酸プロテオグリカンモノクローン抗体、それを産生するハイブリドーマおよびこのモノクローン抗体を用いる低密度型ヘパラン硫酸プロテオグリカンの検出方法
WO1990007712A1 (de) * 1988-12-23 1990-07-12 Bissendorf Peptide Gmbh Antigen, assoziiert mit degenerativen erscheinungen des zentralen nervensystems (zns), dagegen gerichtete antikörper sowie verfahren zur diagnose von dysfunktionen des zns
WO1990012033A1 (en) * 1989-03-29 1990-10-18 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
AU2561792A (en) * 1991-09-06 1993-04-05 Children's Medical Center Corporation Cell-type specific heparan sulfate proteoglycans and their uses

Also Published As

Publication number Publication date
JP3103377B2 (ja) 2000-10-30
HU9302030D0 (en) 1993-11-29
JPH06504616A (ja) 1994-05-26
WO1992013274A1 (en) 1992-08-06
CA2100077A1 (en) 1992-07-16
FI933211A0 (fi) 1993-07-15
PT100008B (pt) 1999-06-30
ATE166157T1 (de) 1998-05-15
AU9071391A (en) 1992-08-27
NO932552D0 (no) 1993-07-14
PT100008A (pt) 1993-02-26
DE69129417D1 (de) 1998-06-18
SK73893A3 (en) 1993-11-10
ZA92271B (en) 1992-10-28
BG97950A (bg) 1995-02-28
EP0816851A2 (en) 1998-01-07
CZ137293A3 (en) 1994-01-19
EP0569367B1 (en) 1998-05-13
AU650936B2 (en) 1994-07-07
CA2100077C (en) 1999-11-16
BG61625B1 (bg) 1998-01-30
FI104347B1 (fi) 1999-12-31
US5422243A (en) 1995-06-06
EP0569367A1 (en) 1993-11-18
PL168188B1 (pl) 1996-01-31
SK281583B6 (sk) 2001-05-10
NZ241273A (en) 1993-10-26
NO314604B1 (no) 2003-04-14
EP0816851A3 (en) 2000-08-23
FI933211A (fi) 1993-09-15
DK0569367T3 (da) 1998-10-07
ES2116331T3 (es) 1998-07-16
HU215778B (hu) 1999-02-01
IE920107A1 (en) 1992-07-15
DE69129417T2 (de) 1998-11-05
CZ282203B6 (cs) 1997-05-14
IE990011A1 (en) 2000-11-01
KR0162670B1 (ko) 1999-05-01
FI104347B (fi) 1999-12-31
RU2139540C1 (ru) 1999-10-10
HUT67587A (en) 1995-04-28

Similar Documents

Publication Publication Date Title
NO932552D0 (no) Deteksjon av syndekaninnholdet i biologisk materiale saasom vevs- og kroppsvaesker for angivelse av malign transformasjon av celler
GR3036073T3 (en) Analytical test apparatus with on board negative and positive control.
DE68923720T2 (de) Einrichtung und Gerät für die Detektion von Mikroorganismen.
CA2035728A1 (en) Device and methods for detecting microorganisms
AU4492493A (en) Method for detecting and determining mediators
DE69033796D1 (de) Verfahren und gerät zum nachweis und zur quantifizierung von glukose in körperflüssigkeiten
MY110532A (en) Enhanced detection of microorganisms in samples
WO1997033147A3 (de) Analyseverfahren unter verwendung von porösem silicium zur erfassung einer substanz oder der konzentration einer substanz in lösungen sowie eine analyseeinrichtung für ein solches verfahren
AU8877291A (en) Methods and sensor systems for sensing hydrocarbon-containing fluids based on fluorescence detection
RU93051783A (ru) Способ обнаружения озлокачествления
AU563306B2 (en) A method of detecting or determining histamine in histamine containing materials, particularly body fluids and an analytical means for use in such method
IT8921788A0 (it) Reattivo utile per la rilevazione e la determinazione quantitativa dei leucociti in fluidi biologici.
EP0185285A3 (en) Liquid level measurement apparatus
IT1233755B (it) Reattivo per la ricerca e la determinazione della bilirubina nelle urine.
ATE182987T1 (de) Nachweisverfahren und vorrichtung dafür
WO1997016713A3 (de) Verfahren und vorrichtung zur bestimmung von rheologischen und mechanischen stoffkenngrössen
AU7871491A (en) Method for determining a specific ligand in a fluid sample with the aid of an evanescent field, and also a component of the requisite measuring equipment suitable for this purpose
DK0431567T3 (da) Fremgangsmåde til påvisning af et småcellet bronchial-carcinom
SE8403682L (sv) Reagens for bestemning av vattenahlten i en produkt samt anvendning av reagenset
NO891535D0 (no) Metode for enkel paavisning og/eller kvantifisering av analytter i kroppsvaesker.
NO964803D0 (no) Fremgangsmåte for måling av konsentrasjonen av glykoler/polyglykoler i fluiden, måleinstrument samt analysesett
ATE85428T1 (de) Sensor zur aufspuerung und lokalisierung von fluessigkeitsundichtigkeiten.